Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03443206 · ClinicalTrials.gov registry record · NA

Loves Company: Combatting Emotional Disturbance in the Digital Age

A NA study of Adolescent - Emotional Problem, sponsored by Northwell Health.

Completed
Registry status
NA
Development phase
212
Enrollment target
1
Study location

NCT03443206 is a NA study of Adolescent - Emotional Problem that has completed, run by Northwell Health. The registered enrollment target is 212 participants, roughly in line with the 214-participant average among 4 other Adolescent - Emotional Problem trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03443206, a NA study of Adolescent - Emotional Problem, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
NA
Development phase
212 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to determine whether a community-based website that is intended to provide support for adolescents experiencing psychological distress can improve members' mental health outcomes. The investigators want to understand if a digital platform can help young people who are suffering and may be unlikely to access more traditional forms of mental health services.

Interventions

  • OTHER anonymous social support
  • OTHER psychoeducation
  • OTHER online resources

Study Locations (1)

New York

  • Northwell Health - Glen Oaks

Trial Details

FieldValue
Enrollment Target 212 participants
Start Date 2020-06-20
Est. Completion 2021-07-31
Phase NA

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT03443206

The ClinicalTrials.gov registry entry for NCT03443206 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 214-participant average among 4 other Adolescent - Emotional Problem trials with a reported enrollment target. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Adolescent - Emotional Problem appearing as the primary indexed condition, and to 3 interventions - of which anonymous social support is the first listed.

NCT03443206 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03443206 about?

NCT03443206 is a clinical study titled "Loves Company: Combatting Emotional Disturbance in the Digital Age". The goal of this study is to determine whether a community-based website that is intended to provide support for adolescents experiencing psychological distress can improve members' mental health outcomes. The investigators want to understand if a digital platform can help young people who are suffe...

What is the current status of trial NCT03443206?

This trial is currently completed. It is a NA study. The enrollment target is 212 participants. The study started on 2020-06-20. Estimated completion is 2021-07-31.

What conditions does trial NCT03443206 study?

This clinical trial studies the following conditions: Adolescent - Emotional Problem.

What interventions are being tested in trial NCT03443206?

The interventions under investigation include: anonymous social support (OTHER), psychoeducation (OTHER), online resources (OTHER).

Who is sponsoring clinical trial NCT03443206?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03443206 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adolescent - Emotional Problem

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.